Cancer-related investigator-initiated trials with an intervention involving a drug, device, or biologic are subject to review by the Data and Safety Monitoring Committee (DSMC).
DSMC reviews study information depending on type of trial (as outlined below) and may recommend continuation, suspension, or closure of a study.
A DSMC Annual Renewal Form is required for all studies undergoing review by the DSMC.
Study Information Reviewed by the DSMC
DSMC Membership
Samantha Culwell, PharmD
Pharmacy